Clinical trial
Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
NCT00357565 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00357565 |
|---|---|
| Title | Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia |
| Official title | Hematopoietic Cell Transplantation in the Treatment of Infant Leukemia and Myelodysplastic Syndrome |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes, Childhood Acute Myeloid Leukemia in Remission, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Previously Treated Myelodysplastic Syndrome, Secondary Myelodysplastic Syndrome, Refractory Anemia With Excess Blasts in Transformation, Refractory Anemia With Excess Blasts and 3 more |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, busulfan, cyclosporine, fludarabine phosphate, melphalan, mycophenolate mofetil, umbilical cord blood transplantation |
| Enrollment | 34 |
| Start date | Nov 1, 2005 |
| Primary completion | Jun 1, 2024 |
| Completion | Mar 11, 2025 |
| First posted | Jul 27, 2006 |
| Last update posted | Aug 26, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: